AQUINO, SARA
 Distribuzione geografica
Continente #
EU - Europa 858
AS - Asia 125
NA - Nord America 102
SA - Sud America 12
AF - Africa 2
Totale 1.099
Nazione #
IT - Italia 836
US - Stati Uniti d'America 100
SG - Singapore 44
BD - Bangladesh 27
VN - Vietnam 26
CN - Cina 20
BR - Brasile 7
FI - Finlandia 6
FR - Francia 5
AR - Argentina 4
HK - Hong Kong 4
GB - Regno Unito 3
CA - Canada 2
CH - Svizzera 2
DE - Germania 2
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IN - India 1
LB - Libano 1
LT - Lituania 1
MG - Madagascar 1
OM - Oman 1
RO - Romania 1
SY - Repubblica araba siriana 1
Totale 1.099
Città #
Genoa 402
Genova 270
Vado Ligure 71
Rapallo 63
Singapore 24
San Jose 23
Ashburn 17
Council Bluffs 11
Ho Chi Minh City 10
Beijing 7
Hanoi 6
New York 6
Helsinki 5
Lauterbourg 5
Los Angeles 5
Buffalo 4
Hong Kong 4
Bordighera 3
Orem 3
Frankfurt am Main 2
Memphis 2
Milan 2
Palermo 2
Zurich 2
Antananarivo 1
Araucária 1
Biên Hòa 1
Boardman 1
Bắc Giang 1
Cairo 1
Cardiff 1
Chos Malal 1
Conceição do Coité 1
Damascus 1
Des Moines 1
Florence 1
Florinas 1
Formosa 1
Fortaleza 1
Glace Bay 1
Grand Prairie 1
Haiphong 1
Hollywood 1
Houston 1
Huế 1
Hải Dương 1
Indianapolis 1
Lappeenranta 1
London 1
Massarosa 1
Miami 1
Mumbai 1
Muscat 1
Nottingham 1
Pimenta Bueno 1
Ploieşti 1
Ponte dell'Olio 1
Prato 1
Resistencia 1
Ricardo Rojas 1
Santa Clara 1
Saquarema 1
Schiavon 1
Sidon 1
Talagante 1
Tallinn 1
Turin 1
Ubá 1
Yoakum 1
Zagreb 1
Águas de Lindóia 1
Ân Thi 1
Totale 997
Nome #
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide 236
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 171
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 167
Evidence for killing of Mesenchymal Stem Cells (MSC) by autologous natural killer lymphocytes. 166
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis. 144
Radiomics and artificial intelligence for outcome prediction in multiple myeloma patients undergoing autologous transplantation: A feasibility study with ct data 143
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial 93
Totale 1.120
Categoria #
all - tutte 3.701
article - articoli 3.701
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202268 5 4 5 4 5 4 5 13 6 5 3 9
2022/202377 6 11 0 5 10 7 1 7 6 5 17 2
2023/202496 2 10 11 15 13 4 9 16 2 2 1 11
2024/2025232 14 11 13 17 13 26 14 40 10 19 25 30
2025/2026434 51 9 49 42 50 22 40 24 34 48 56 9
Totale 1.120